These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vivo assessment of hypertensive nephrosclerosis using ultrasound localization microscopy. Qiu L; Zhang J; Yang Y; Zhang H; Lee FF; He Q; Huang C; Huang L; Qian L; Luo J Med Phys; 2022 Apr; 49(4):2295-2308. PubMed ID: 35218672 [TBL] [Abstract][Full Text] [Related]
23. [Molecular factors of angiogenesis in renal tissue of patients with chronic glomerulonephritis: association with nephrosclerosis and anemia]. Shvetsov MIu; Ivanov AA; Kuznetsova AV; Popova OP; Rameeva AS Ter Arkh; 2009; 81(8):14-9. PubMed ID: 19799194 [TBL] [Abstract][Full Text] [Related]
24. Structural and Functional Changes With the Aging Kidney. Denic A; Glassock RJ; Rule AD Adv Chronic Kidney Dis; 2016 Jan; 23(1):19-28. PubMed ID: 26709059 [TBL] [Abstract][Full Text] [Related]
25. Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases. Wei Z; Kwan BC; Chow KM; Cheng PM; Luk CC; Lai KB; Li PK; Szeto CC BMC Nephrol; 2018 Dec; 19(1):367. PubMed ID: 30567508 [TBL] [Abstract][Full Text] [Related]
26. [Clinical and pathological characteristics in patients with clinically presumed hypertensive nephrosclerosis]. Guo YS; Yuan WJ; Yu JP; Mei XB; Ye HY; Bian Q; Xu J Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):391-5. PubMed ID: 16776947 [TBL] [Abstract][Full Text] [Related]
27. Relationship between silent brain infarction and chronic kidney disease. Kobayashi M; Hirawa N; Yatsu K; Kobayashi Y; Yamamoto Y; Saka S; Andoh D; Toya Y; Yasuda G; Umemura S Nephrol Dial Transplant; 2009 Jan; 24(1):201-7. PubMed ID: 18697797 [TBL] [Abstract][Full Text] [Related]
28. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Caetano ER; Zatz R; Saldanha LB; Praxedes JN Hypertension; 2001 Aug; 38(2):171-6. PubMed ID: 11509471 [TBL] [Abstract][Full Text] [Related]
29. Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors. Elsherbiny HE; Alexander MP; Kremers WK; Park WD; Poggio ED; Prieto M; Lieske JC; Rule AD Clin J Am Soc Nephrol; 2014 Nov; 9(11):1892-902. PubMed ID: 25318758 [TBL] [Abstract][Full Text] [Related]
30. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy. Racca MA; Novoa PA; Rodríguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305 [TBL] [Abstract][Full Text] [Related]
31. The diagnostic dilemma of hypertensive nephrosclerosis: the nephrologist's view. Zucchelli P; Zuccalà A Am J Kidney Dis; 1993 May; 21(5 Suppl 2):87-91. PubMed ID: 8494026 [TBL] [Abstract][Full Text] [Related]
32. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Marín R; Gorostidi M; Fernández-Vega F; Alvarez-Navascués R Kidney Int Suppl; 2005 Dec; (99):S52-6. PubMed ID: 16336577 [TBL] [Abstract][Full Text] [Related]
33. The association between age and nephrosclerosis on renal biopsy among healthy adults. Rule AD; Amer H; Cornell LD; Taler SJ; Cosio FG; Kremers WK; Textor SC; Stegall MD Ann Intern Med; 2010 May; 152(9):561-7. PubMed ID: 20439574 [TBL] [Abstract][Full Text] [Related]
34. [Features of chronic kidney disease in elderly patients.]. Kurochkina ON Adv Gerontol; 2020; 33(1):113-120. PubMed ID: 32362093 [TBL] [Abstract][Full Text] [Related]
35. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Innes A; Johnston PA; Morgan AG; Davison AM; Burden RP Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642 [TBL] [Abstract][Full Text] [Related]
36. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled 'hypertensive nephrosclerosis'. Kincaid-Smith P J Hypertens; 2004 Jun; 22(6):1051-5. PubMed ID: 15167435 [TBL] [Abstract][Full Text] [Related]
37. Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar Nephrosclerosis. Momoki K; Kataoka H; Moriyama T; Mochizuki T; Nitta K J Atheroscler Thromb; 2017 Jun; 24(6):630-642. PubMed ID: 27784849 [TBL] [Abstract][Full Text] [Related]